Sonnet BioTherapeutics
SONN
SONN
10 hedge funds and large institutions have $118K invested in Sonnet BioTherapeutics in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Renaissance Technologies
New York
|
$0 |
2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
3 |
3
Morgan Stanley
New York
|
$11 |
4 |
4
BlackRock
New York
|
$967 |
5 |
5
Osaic Holdings
Scottsdale,
Arizona
|
$0 |